LABD · ARCA · ETF
Direxion Daily S&P Biotech Bear 3X ETF (LABD) Price, Holdings & Fees
Direxion Daily S&P Biotech Bear 3X ETF (LABD) closed at $674.44 on Oct 9, 2026, up 1.30% from the previous close of $665.77.
Share price, past year
1Y +6.51%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $674.44 |
| Sep 30, 2026 | $655.87 |
| Aug 31, 2026 | $667.63 |
| Jul 31, 2026 | $638.91 |
| Jun 30, 2026 | $642.89 |
| May 29, 2026 | $589.28 |
| Apr 30, 2026 | $607.98 |
| Mar 31, 2026 | $663.59 |
| Feb 27, 2026 | $652.97 |
| Jan 30, 2026 | $675.99 |
| Dec 31, 2025 | $618.77 |
| Nov 28, 2025 | $625.49 |
| Oct 31, 2025 | $642.50 |
Key statistics
- Expense ratio
- —
- Net assets
- $54.2M
- as of Jul 31, 2026
- Holdings
- 10
- as of Jul 31, 2026
- 52-week range
- $589.21 – $684.83
Holdings
Direxion Daily S&P Biotech Bear 3X ETF held 10 investments worth $54.20M as of Jul 31, 2026. Its largest holding was GOLDMAN FINANCIAL, at 52.74% of the fund.
| # | Holding | % of fund | Value |
|---|---|---|---|
| 1 | GOLDMAN FINANCIAL | 52.74% | $28.59M |
| 2 | DREYFUS | 40.47% | $21.93M |
| 3 | GOLDMAN SACHS LIQ ES FD A | 26.30% | $14.26M |
| 4 | DREYFUS | 18.03% | $9.77M |
| 5 | N/A | 2.98% | $1.61M |
| 6 | N/A | 1.43% | $772.87K |
| 7 | N/A | −1.55% | −$842.24K |
| 8 | N/A | −4.11% | −$2.23M |
| 9 | N/A | −4.88% | −$2.65M |
| 10 | N/A | −6.37% | −$3.45M |
Top 10 of 10 holdings, as of Jul 31, 2026. Percentages are of the fund's net assets.
What the fund owns
| Asset type | % of fund |
|---|---|
| Cash and short-term investments | 137.54% |
| Other derivatives | −12.51% |
| Country | % of fund |
|---|---|
| United States | 125.03% |
Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.
Monthly total returns
Over the 3 months to Jul 31, 2026, Direxion Daily S&P Biotech Bear 3X ETF's total return was −36.36%, as reported to the SEC.
| Month | Total return |
|---|---|
| Jul 31, 2026 | +20.97% |
| Jun 30, 2026 | −39.07% |
| May 31, 2026 | −13.66% |
The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.
Fund profile
- Name
- Direxion Daily S&P Biotech Bear 3X ETF
- Ticker
- LABD
- Exchange
- ARCA
- Fund type
- ETF
- Trust
- Direxion Shares ETF Trust
- SEC series ID
- S000049374
- SEC CIK
- 0001424958
- Fractional shares
- Yes
Recent SEC filings
- Sep 28, 2026
- 485BPOSProspectus updateAug 10, 2026
- 485BPOSProspectus updateJul 21, 2026
- 485BPOSProspectus updateJul 10, 2026
- Jul 8, 2026
- 485BPOSProspectus updateJun 8, 2026
- 485BPOSProspectus updateMay 29, 2026
- 485BPOSProspectus updateApr 29, 2026
Shareholder reports and prospectuses are filed by Direxion Shares ETF Trust, the trust behind Direxion Daily S&P Biotech Bear 3X ETF, and cover all of its funds.
Frequently asked questions
What is LABD's price?
Direxion Daily S&P Biotech Bear 3X ETF (LABD) closed at $674.44 on Oct 9, 2026, up 1.30% from the previous close of $665.77.
What does LABD hold?
Direxion Daily S&P Biotech Bear 3X ETF held 10 investments worth $54.20M as of Jul 31, 2026. Its largest holding was GOLDMAN FINANCIAL, at 52.74% of the fund. Its five largest holdings were GOLDMAN FINANCIAL, DREYFUS, GOLDMAN SACHS LIQ ES FD A, DREYFUS, N/A.
How has LABD performed?
Over the 3 months to Jul 31, 2026, Direxion Daily S&P Biotech Bear 3X ETF's total return was −36.36%, as reported to the SEC.
Sources and methodology
Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jul 31, 2026 (filed Sep 28, 2026). Prices are generated sample data for development. Data sources and disclosures